Drug Identity
Active Ingredient
Tenofovir Disoproxil
Drug Class
Antivirals For Systemic Use
Chemical Class
Adenosine analog
Pharmacological Group
on the basis of mechanism of action
ATC Code
J05AF07
Status
Essential Medicine
What is Viread?
Uses
Tenofovir is an antiviral medicine that is used to treat HIV, the virus that can cause acquired immunodeficiency syndrome (AIDS). Tenofov...
How It Works
Chemical Class
Adenosine analog
Pharmacological Group
on the basis of mechanism of action
It is of Semi Synthetic origin and belongs to Adenosine analog. It belongs to Antiviral Agents pharmacological group on the basis of mechanism of action.
How to Take It
1
Adult · PO
300 mg — As recommended.
2
Adult
Scraped Dose
Before you start treatment with tenofovir, your doctor may perform tests to make sure you do not have HIV (if you are being treated for hepatitis B) or hepatitis B (if you are being treated for HIV
Safety Alerts
You should not take tenofovir if you are allergic to it
Do not take tenofovir together with adefovir (Hepsera), or with combination medicines that contain tenofovir (Atripla, Biktarvy , Cimduo, Complera , Descovy, Genvoya, Odefsey, Stribild , Symfi, or Truvada)
Tell your doctor if you have ever had: liver disease (especially hepatitis B if you also have HIV)
HIV (if you are taking tenofovir to treat hepatitis B)
or low bone mineral density
Important Warnings
When treating chronic hepatitis B with tenofovir, monitor liver function tests every 3 months and viral markers for hepatitis B every 3-6 months during treatment (continue monitoring for at least 1 year after discontinuation
recurrent hepatitis may occur on discontinuation), renal or hepatic impairment, hyperphosphataemia
Monitor renal function before treatment, every 4 weeks during first year, then every 3 months
reduce dose or interrupt therapy if serum phosphate or creatinine clearance is decreased
Risk of immune reactivation syndrome in patients with severe immune deficiency within first few weeks or months or starting combination antiretroviral therapy, Risk of osteonecrosis
monitor for signs of joint pain or immobility
Reduced bone mineral density, elderly, Cirrhosis
monitor for hepatic decompensation
Side Effects
Hypophosphataemiareduced bonedensityhyperphosphataemiadizzinessheadacheraised ALT fatiguepancreatitisrashrenal abnormalities lactic acidosisGI disturbance. Rare: Nephrogenic diabetes insipidusproximal renal tubulopathyrenal failure
Drug Interactions
Nephrotoxic drugs
drugs eliminated by active tubular secretion
nucleoside analogues
atazanavir
didanosine
adefovir
tacrolimus. Triple therapy with lamivudine
plus abacavir
Pregnancy & Lactation
Pregnancy
Caution advised, avoid
Lactation
Caution advised, avoid
Storage
Tabs Store in a well closed container, at room temperature, Between 15°C-30°C. Protect from Sunlight, Moisture and Heat.
Price Intelligence
Rs 6,557.62
DRAP approved maximum price · per pack of 30 · approved 04 Aug, 2025
No retail price observed for this pack. Retailers may not exceed the approved maximum.
Prices across sources
No retail prices recorded
Should you consider an alternative?
Other options containing Tenofovir Disoproxil, and what they are not.
Identical active ingredient at the same strength. Cheapest per unit first.
Ordered by lowest price per unit where a pack size is known, then by price. Order is never affected by sponsorship. Not medical advice — confirm any change with your pharmacist or doctor.
For pharma professionalsCompany, market and opportunity intelligence
Company
427
brands
409
molecules
1
alerts